Framework agreement for the supply of short- and long-acting G-CSF medicines

Summary

Hospilim VZW is procuring short- and long-acting granulocyte colony-stimulating factor (G-CSF) medicines in a framework agreement covering two lots: short-acting products and long-acting products, both for subcutaneous administration in prefilled syringes. Each lot is planned for 36 months, and the framework agreement may include up to 20 suppliers. The procurement covers delivery locations in Belgium.